Skip to main content
Menu
Book Exam
Directions
Boy-Smiling-in-Grass-1280x480

Forms of Macular Degeneration

There are two forms of macular degeneration, dry (non-neovascular) or wet (neovascular). The term neovascular refers to the growth of new blood vessels.

Dry AMD (non-neovascular)

Dry AMD is the most common form of the disease, making up about 85%-90% of all cases of AMD. It is characterized by blurred central vision or blind spots, as the macula begins to deteriorate. Dry AMD is an early stage of the disease and is less severe than the wet form,.

Dry AMD occurs when the aging tissues of the macula begin to thin out and break down. Tiny pieces of white or yellowish protein called drusen begin to appear, which are thought to be deposits from the macular tissue as it deteriorates. The appearance of these drusen are often what leads to a diagnosis of AMD during an eye exam.

With dry AMD vision loss happens gradually, however, the dry form can progress to wet AMD rapidly. There is currently no cure for dry AMD, however there is research that shows that some people can benefit from supplemental vitamin therapy including antioxidants, lutein and zeaxanthin.

Wet AMD (neovascular)

Wet AMD is less common occurring in only about 10 percent of those with AMD. AMD is classified as Wet AMD when abnormal blood vessels begin to grow under the retina and leak fluid and blood into the macula, resulting in blind spots and a loss of central vision. Wet AMD can cause more damage to vision and permanent scarring if not treated quickly, so any sudden blur in vision should be assessed immediately, especially if one is aware that they have AMD. Usually vision loss happens faster and is more noticeable than in dry AMD so the quicker it is treated, the more vision you can preserve.

x
Most people between the ages of 40-45 start to have difficulty seeing up close. This is called Presbyopia and slowly progresses until about the age of 65. This is a normal change due to the lens in the eye hardening and losing flexibility.

Vuity is 1.25% pilocarpine. This is not a new drug. It has been on the market for decades and is used to temporarily shrink the pupil size. It is now being rebranded as a drop that can help improve near vision. How does this work? By shrinking the pupil size, physics tells us this can increase our depth of focus. This drop will not CURE presbyopia. It can improve it while the drop is active and the near blur will return when the dose wears off after approximately 4-6 hours. This drop is recommended for individuals ages 40-55.

Dosage: one drop in each eye once per day. Side effects: possible brown ache or a mild headache. The cost at this time is about $80-90 per month at most pharmacies and insurance does not apply.